Form 4: Eli Lilly Director J. Erik Fyrwald Increases Stake Through Stock Unit Acquisition

Eli Lilly & Co. Director J. Erik Fyrwald acquired 12.279 shares of common stock at $807.58 per share, deferring them as stock units under the company's Directors' Deferral Plan.

Summary

• J. Erik Fyrwald, a Director at Eli Lilly & Co. (LLY), acquired 12.279 shares of common stock on June 16, 2025.
• The acquisition price was $807.58 per share.
• Following this transaction, Mr. Fyrwald directly beneficially owns 72,999.768 shares of Eli Lilly common stock.
• These shares were acquired as stock units under the Lilly Directors' Deferral Plan, in lieu of cash compensation, and will be settled in common stock upon Mr. Fyrwald's separation from service.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if part of a compensation plan, generally indicates alignment of interests and confidence in the company's long-term prospects. It's a positive signal, though not a discretionary market buy.

Positives

• Increased insider ownership by a Director, which can signal confidence in the company's future performance.
• The acquisition is part of a compensation deferral plan, aligning the director's long-term interests with shareholders.

Future Outlook

The acquired shares, deferred as stock units, are expected to be settled in common stock following the reporting person's separation from service, indicating a long-term holding strategy.

Industry Context

This transaction is a routine insider filing for a director at a major pharmaceutical company, Eli Lilly & Co., and does not directly reflect broader industry trends, though it highlights common executive compensation practices in the sector.

Related Party Transactions

• The acquisition of shares as stock units under the Lilly Directors' Deferral Plan represents a transaction between the company and a director, which is a form of related party transaction related to compensation.

Stakeholder Impact

• Shareholders: Increased alignment of a director's financial interests with those of shareholders due to deferred stock compensation.

Next Steps

• Settlement of deferred stock units into common stock upon J. Erik Fyrwald's separation from service.

Key Dates

Recommendation

Keywords

Eli Lilly, LLY, Form 4, Insider Trading, Stock Acquisition, Director Compensation, Stock Units, Deferred Compensation, Pharmaceuticals, Biotechnology